![Caroline Chevalier](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Caroline Chevalier
Geen lopende functies
Loopbaan van Caroline Chevalier
Eerdere bekende functies van Caroline Chevalier
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
DECIPHERA PHARMACEUTICALS, INC. | Human Resources Officer | 01-01-2018 | 01-10-2021 |
TESARO INC | Human Resources Officer | - | - |
Gestionova SAS
![]() Gestionova SAS Miscellaneous Commercial ServicesCommercial Services Gestionova SAS operates as a holding company with interests in the provision of maintenance and building services. Through its subsidiaries, it offers solutions for air conditioning, heating, plumbing, waterproofing, and electricity. The company was founded on October 5, 1998 and is headquartered in Velizy-Villacoublay, France. | Corporate Officer/Principal | - | - |
Opleiding van Caroline Chevalier
Boston College | Undergraduate Degree |
Statistieken
Internationaal
Verenigde Staten | 4 |
Frankrijk | 2 |
Operationeel
Human Resources Officer | 2 |
Corporate Officer/Principal | 1 |
Undergraduate Degree | 1 |
Sectoraal
Health Technology | 3 |
Commercial Services | 2 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 3 |
---|---|
Gestionova SAS
![]() Gestionova SAS Miscellaneous Commercial ServicesCommercial Services Gestionova SAS operates as a holding company with interests in the provision of maintenance and building services. Through its subsidiaries, it offers solutions for air conditioning, heating, plumbing, waterproofing, and electricity. The company was founded on October 5, 1998 and is headquartered in Velizy-Villacoublay, France. | Commercial Services |
Deciphera Pharmaceuticals, Inc.
![]() Deciphera Pharmaceuticals, Inc. BiotechnologyHealth Technology Deciphera Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering important new medicines to patients for the treatment of cancer. The firm designs a drug candidate, DCC-2618, to inhibit the full spectrum of mutant or amplified KIT and PDGFRa kinases that drive cancers such as gastrointestinal stromal tumors, advanced systemic mastocytosis, gliomas, and other solid tumors. The company was founded by Peter A. Petillo and Daniel L. Flynn in 2003 and is headquartered in Waltham, MA. | Health Technology |
Tesaro, Inc.
![]() Tesaro, Inc. Pharmaceuticals: MajorHealth Technology TESARO, Inc. is an oncology-focused biopharmaceutical company, which engages in the research and development of biopharmaceutical products. The firm offers Niraparib products. The company was founded by Leon Oliver Moulder, Jr., Mary Lynne Hedley, and Richard J. Rodgers on March 26, 2010 and is headquartered in Waltham, MA. | Health Technology |
- Beurs
- Insiders
- Caroline Chevalier
- Ervaring